Conditions: Multiple Sclerosis
Keywords: Relapsing Remitting
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1106
Healthy volunteers: no

Brief summary:
Determination the efficacy of daily oral treatment with laquinimod 0.6 mg capsules as compared to placebo in subjects with Relapsing Remitting Multiple Sclerosis (RRMS).

Detailed description:

Arms:
arm 1: Laquinimod 0.6 mg, oral arm 2: Matching placebo

Interventions: intervention 1: Laquinimod intervention 2: Placebo
Intervention descriptions: intervention 1: Laquinimod 0.6 mg capsule, oral, once daily intervention 2: oral, once daily, capsule

Protocol document: